Biogen (BIIB) had the highest return between September 1, 1995 and January 31, 1996 by a large-cap US stock, returning 207.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
Biogen (BIIB) | 9/1/1995 - 1/31/1996 | 207.13% |
Arrowhead Pharmaceuticals (ARWR) | 9/1/1995 - 1/31/1996 | 188.89% |
AngloGold Ashanti (AU) | 9/1/1995 - 1/31/1996 | 100% |
Gartner (IT) | 9/1/1995 - 1/31/1996 | 95.58% |
Incyte (INCY) | 9/1/1995 - 1/31/1996 | 80.35% |
NetApp (NTAP) | 9/1/1995 - 1/31/1996 | 78.25% |
Gilead Sciences (GILD) | 9/1/1995 - 1/31/1996 | 70.25% |
Cadence Design Systems (CDNS) | 9/1/1995 - 1/31/1996 | 61.9% |
Telkom Indonesia (Persero) Tbk PT ADR Rep 100 B (TLK) | 9/1/1995 - 1/31/1996 | 61.84% |
Becton Dickinson and (BDX) | 9/1/1995 - 1/31/1996 | 54.57% |
Humana (HUM) | 9/1/1995 - 1/31/1996 | 52.41% |
TJX Companies (TJX) | 9/1/1995 - 1/31/1996 | 51.01% |
Nike (NKE) | 9/1/1995 - 1/31/1996 | 50.76% |
Pfizer (PFE) | 9/1/1995 - 1/31/1996 | 47.95% |
IDEXX Laboratories (IDXX) | 9/1/1995 - 1/31/1996 | 47.79% |
UnitedHealth (UNH) | 9/1/1995 - 1/31/1996 | 47.65% |
Universal Health Services (UHS) | 9/1/1995 - 1/31/1996 | 45.62% |
Chubb (CB) | 9/1/1995 - 1/31/1996 | 44.6% |
Ross Stores (ROST) | 9/1/1995 - 1/31/1996 | 43% |
Cigna (CI) | 9/1/1995 - 1/31/1996 | 42.46% |
Merck (MRK) | 9/1/1995 - 1/31/1996 | 41.96% |
Aon (AON) | 9/1/1995 - 1/31/1996 | 41.04% |
Intuit (INTU) | 9/1/1995 - 1/31/1996 | 40.85% |
Eli Lilly and (LLY) | 9/1/1995 - 1/31/1996 | 40.84% |
CoreSite Realty (COR) | 9/1/1995 - 1/31/1996 | 40.45% |
Large-cap stocks are treated as having a market cap of $10B+.